New findings about N-Nitrosodimethylamine (NDMA) contamination of this type of heartburn medication led to the U.S. Food and Drug Administration’s (FDA’s) more drastic action.
Zantac, Ranitidine Pulled From Market, Here Are FDA’s Latest Cancer Concerns
